Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Eris Lifesciences Limited
  6. Company
    540596   INE406M01024

ERIS LIFESCIENCES LIMITED

(540596)
  Report
End-of-day quote Bombay Stock Exchange  -  2022-10-05
731.10 INR   -1.21%
09/09Eris Lifesciences : ESOP/ESPS/SBEB Scheme
PU
08/25Eris Lifesciences Seeks Acquisitions
CI
08/05Eris Lifesciences Limited Provides Revenue Guidance for the Year 2023
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Eris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals and nutrients (VMN). The Company's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited and Eris Healthcare Private Limited.

Number of employees : 3 619 people.
Sales per Business
20212022Delta
Pharmaceutical Products11 926.4098.4%13 261.7098.5% +11.2%
Goods and Services Tax Refund189.761.6%206.411.5% +8.77%
Others2.43-2.34- -3.7%
INR in Million
Sales per region
20212022Delta
India12 118.60100%13 470.40100% +11.15%
INR in Million
Managers
Name Title Age Since
Amit Indubhushan Bakshi Chairman & Managing Director 47 2007
Vijay S. Joshi President - 2010
Sachin Shah Senior Manager-Finance & Processes 41 2013
Krishnakumar Vaidyanathan Chief Operating Officer & Executive Director 46 2020
Milind Talegaonkar Secretary & Compliance Officer 45 2016
Members of the board
Name Title Age Since
Amit Indubhushan Bakshi Chairman & Managing Director 47 2007
Prashant Gupta Independent Non-Executive Director 41 2018
Rajeev Dalal Independent Non-Executive Director 63 2020
Kalpana Unadkat Independent Non-Executive Director 50 2021
Sujesh Vasudevan Independent Non-Executive Director - 2022
Inderjeet Singh Negi Executive Non-Independent Director 49 2007
Krishnakumar Vaidyanathan Chief Operating Officer & Executive Director 46 2020
Kaushal Kamlesh Shah Executive Director - 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 135,990,717 29,295,585 21.5% 0 0.0% 21.5%
Shareholders
NameEquities%
Amit Indubhushan Bakshi 54,698,423 40.2%
Rakeshbhai Bhikhabhai Shah 15,684,407 11.5%
Bhikhabhai Chimanlal Shah 8,892,430 6.54%
UTI Asset Management Co. Ltd. (Investment Management) 8,521,323 6.27%
Emerald Investments Ltd. 7,477,132 5.50%
Rajendra Rambhai Patel 5,939,834 4.37%
Inderjeet Singh Negi 5,939,833 4.37%
Kaushal Kamlesh Shah 4,468,833 3.29%
Hetal Rasiklal Shah 3,822,175 2.81%
Himanshu Jayantbhai Shah 2,457,011 1.81%
Company contact information
Eris Lifesciences Ltd.
Commerce House IV, Prahladnagar
Besides Shell Petrol Pump
100 Feet Road,8th Floor
Ahmedabad, Gujarat 380015

Phone : +91.79.30451111
Fax : +91.79.30179404
Web : http://www.eris.co.in
Brand Portfolio
In partnership withAllbrands.markets
More brands of Eris Lifesciences Limited
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ERIS LIFESCIENCES LIMITED-3.66%1 232
JOHNSON & JOHNSON-3.48%434 104
ELI LILLY AND COMPANY19.43%315 249
ROCHE HOLDING AG-13.48%273 724
ABBVIE INC.5.86%253 421
PFIZER, INC.-25.28%247 617
NOVO NORDISK A/S7.88%237 650
MERCK & CO., INC.15.33%223 917
ASTRAZENECA PLC14.59%173 324
NOVARTIS AG-4.90%169 105
BRISTOL-MYERS SQUIBB COMPANY14.21%152 564
AMGEN INC.3.93%125 078
SANOFI-9.27%99 367
GILEAD SCIENCES, INC.-9.86%82 033
GSK PLC-19.14%60 521
DAIICHI SANKYO CO., LTD.44.82%56 079
BAYER AG3.51%47 121
CHUGAI PHARMACEUTICAL CO., LTD1.95%43 263
TAKEDA PHARMACEUTICAL COMPANY LIMITED22.60%41 215
JIANGSU HENGRUI MEDICINE CO., LTD.-30.78%31 468
ASTELLAS PHARMA INC.6.44%25 062
Connections : Eris Lifesciences Limited